163 related articles for article (PubMed ID: 10022444)
1. Brain natriuretic peptide and neutral endopeptidase inhibition in left ventricular impairment.
Lainchbury JG; Richards AM; Nicholls MG; Espiner EA; Yandle TG
J Clin Endocrinol Metab; 1999 Feb; 84(2):723-9. PubMed ID: 10022444
[TBL] [Abstract][Full Text] [Related]
2. Neutral endopeptidase inhibition potentiates the effects of natriuretic peptides in renin transgenic rats.
Wegner M; Ganten D; Stasch JP
Hypertens Res; 1996 Dec; 19(4):229-38. PubMed ID: 8986453
[TBL] [Abstract][Full Text] [Related]
3. Differing biological effects of equimolar atrial and brain natriuretic peptide infusions in normal man.
Hunt PJ; Espiner EA; Nicholls MG; Richards AM; Yandle TG
J Clin Endocrinol Metab; 1996 Nov; 81(11):3871-6. PubMed ID: 8923831
[TBL] [Abstract][Full Text] [Related]
4. Role of neutral endopeptidase 24.11 in AV fistular rat model of heart failure.
Wegner M; Hirth-Dietrich C; Stasch JP
Cardiovasc Res; 1996 Jun; 31(6):891-8. PubMed ID: 8759244
[TBL] [Abstract][Full Text] [Related]
5. Clearance receptors and endopeptidase: equal role in natriuretic peptide metabolism in heart failure.
Rademaker MT; Charles CJ; Kosoglou T; Protter AA; Espiner EA; Nicholls MG; Richards AM
Am J Physiol; 1997 Nov; 273(5):H2372-9. PubMed ID: 9374774
[TBL] [Abstract][Full Text] [Related]
6. Brain natriuretic peptide enhances renal actions of furosemide and suppresses furosemide-induced aldosterone activation in experimental heart failure.
Cataliotti A; Boerrigter G; Costello-Boerrigter LC; Schirger JA; Tsuruda T; Heublein DM; Chen HH; Malatino LS; Burnett JC
Circulation; 2004 Apr; 109(13):1680-5. PubMed ID: 15023890
[TBL] [Abstract][Full Text] [Related]
7. Enhanced natriuretic response to neutral endopeptidase inhibition in heart-transplant recipients.
Geny B; Hardy H; Lonsdorfer J; Eisenmann B; Haberey P; Piquard F
Hypertension; 1999 Apr; 33(4):969-74. PubMed ID: 10205232
[TBL] [Abstract][Full Text] [Related]
8. Acute inhibition of endopeptidase 24.11 in essential hypertension: SCH 34826 enhances atrial natriuretic peptide and natriuresis without lowering blood pressure.
Richards AM; Crozier IG; Espiner EA; Ikram H; Yandle TG; Kosoglou T; Rallings M; Frampton C
J Cardiovasc Pharmacol; 1992; 20(5):735-41. PubMed ID: 1280735
[TBL] [Abstract][Full Text] [Related]
9. Reversal of cardiac hypertrophy and fibrosis by S21402, a dual inhibitor of neutral endopeptidase and angiotensin converting enzyme in SHRs.
Farina NK; Johnston CI; Burrell LM
J Hypertens; 2000 Jun; 18(6):749-55. PubMed ID: 10872560
[TBL] [Abstract][Full Text] [Related]
10. Low-dose brain natriuretic peptide infusion in normal men and the influence of endopeptidase inhibition.
Florkowski CM; Richards AM; Espiner EA; Yandle TG; Sybertz E; Frampton CM
Clin Sci (Lond); 1997 Mar; 92(3):255-60. PubMed ID: 9093005
[TBL] [Abstract][Full Text] [Related]
11. Hormonal, renal, hemodynamic responses to acute neutral endopeptidase inhibition in heart transplant patients.
Piquard F; Richard R; Charloux A; Doutreleau S; Hannedouche T; Brandenberger G; Geny B
J Appl Physiol (1985); 2002 Aug; 93(2):569-75. PubMed ID: 12133866
[TBL] [Abstract][Full Text] [Related]
12. Renal, endocrine, and hemodynamic effects of human brain natriuretic peptide in normal man.
Holmes SJ; Espiner EA; Richards AM; Yandle TG; Frampton C
J Clin Endocrinol Metab; 1993 Jan; 76(1):91-6. PubMed ID: 8380606
[TBL] [Abstract][Full Text] [Related]
13. B-type natriuretic peptide infusions in acute myocardial infarction.
Hillock RJ; Frampton CM; Yandle TG; Troughton RW; Lainchbury JG; Richards AM
Heart; 2008 May; 94(5):617-22. PubMed ID: 17639095
[TBL] [Abstract][Full Text] [Related]
14. Bioactivity and interactions of adrenomedullin and brain natriuretic peptide in patients with heart failure.
Lainchbury JG; Nicholls MG; Espiner EA; Yandle TG; Lewis LK; Richards AM
Hypertension; 1999 Jul; 34(1):70-5. PubMed ID: 10406826
[TBL] [Abstract][Full Text] [Related]
15. Combined endopeptidase inhibition and adrenomedullin in sheep with experimental heart failure.
Rademaker MT; Charles CJ; Cooper GJ; Coy DH; Espiner EA; Lewis LK; Nicholls MG; Richards AM
Hypertension; 2002 Jan; 39(1):93-8. PubMed ID: 11799085
[TBL] [Abstract][Full Text] [Related]
16. Brain natriuretic peptide: natriuretic and endocrine effects in essential hypertension.
Richards AM; Crozier IG; Holmes SJ; Espiner EA; Yandle TG; Frampton C
J Hypertens; 1993 Feb; 11(2):163-70. PubMed ID: 8385176
[TBL] [Abstract][Full Text] [Related]
17. Neutral endopeptidase inhibition: augmented atrial and brain natriuretic peptide, haemodynamic and natriuretic responses in ovine heart failure.
Rademaker MT; Charles CJ; Espiner EA; Nicholls MG; Richards AM; Kosoglou T
Clin Sci (Lond); 1996 Sep; 91(3):283-91. PubMed ID: 8869410
[TBL] [Abstract][Full Text] [Related]
18. Interactions of atrial and brain natriuretic peptides at pathophysiological levels in normal men.
Hunt PJ; Espiner EA; Richards AM; Yandle TG; Frampton C; Nicholls MG
Am J Physiol; 1995 Dec; 269(6 Pt 2):R1397-403. PubMed ID: 8594942
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
La Villa G; Lazzeri C; Pascale A; Sestini S; Bisi G; Sciagrà R; Vecchiarino S; Raggi VC; Barletta G; Laffi G; Gentilini P
Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200
[TBL] [Abstract][Full Text] [Related]
20. Plasma concentrations of atrial and brain natriuretic peptides and cyclic guanosine monophosphate in response to dobutamine infusion in patients with surgically repaired tetralogy of fallot.
Hayabuchi Y; Matsuoka S; Kuroda Y
Pediatr Cardiol; 1999; 20(5):343-50. PubMed ID: 10441688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]